Signed · Poland · Pharma and biotech
Abacus Medicine Group agrees to acquire Delfarma.
Copenhagen-based parallel distributor Abacus Medicine Group agreed on 14 September 2026 to buy Delfarma, a Polish parallel importer of medicines with its own repackaging production. The deal marks the group's entry into Poland and needs Polish competition clearance, expected within six to eight weeks. It was signed on 14 September 2026. It had not completed by 28 October 2026.
Signing 14 September 2026
- Buyer
- Abacus Medicine Group ·Copenhagen, Denmark
- Target
- Delfarma ·Lodz, Poland
- Type
- Acquisition
- Announced
- 14 September 2026
- Signed
- 14 September 2026
- Value
- Not disclosed
- People
- Not stated in the release
- Last checked
- 28 October 2026
The people side in Poland
- In a transfer of a workplace or part of it, the new employer becomes party to existing employment relationships by law, and the transfer is no ground for notice of termination. Labour Code (Kodeks pracy), article 23(1) sections 1 and 6
- Old and new employer inform their company unions in writing at least 30 days before the planned transfer, and negotiate for up to 30 days on planned changes to employment terms. Trade Unions Act (ustawa o związkach zawodowych), article 26(1)
- Where no company union operates, both employers inform employees in writing at least 30 days before the transfer. Employees may resign on seven days' notice within two months of it. Labour Code (Kodeks pracy), article 23(1) sections 3 and 4
- Above EUR 1 billion combined worldwide or EUR 50 million Polish turnover, an acquisition of control waits for UOKiK clearance, unless the target's Polish turnover stayed within EUR 10 million in both prior years. Competition and Consumer Protection Act, articles 13, 14 and 97
- Where the deal needs EU merger clearance, the buyer may not implement it before clearance. EU Merger Regulation (Council Regulation (EC) No 139/2004), article 7
- Buyer press release, 14 September 2026 (primary source)
Related deals
- 21 Oct
Indutrade ABto
Sinmed Sp. z o.o.deal page: Indutrade agrees to acquire SinmedSigned
48SigningDay 100 - 20 Oct
Ambrose Healthcareto
AM-Pharma B.V.deal page: Ambrose Healthcare acquires AM-PharmaCompleted
not statedSigningDay 100 - 19 Oct
Merck KGaAto
Silence Therapeutics plcdeal page: Merck KGaA agrees to acquire Silence TherapeuticsSigned
not statedSigningDay 100 - 19 Oct
Indutrade ABto
Euromed Medical Solution Sp. z o.o.deal page: Indutrade agrees to acquire EuromedSigned
40SigningDay 100